AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
276.47
+4.05 (1.49%)
At close: Oct 9, 2026, 4:00 PM EDT
276.46
-0.01 (0.00%)
After-hours: Oct 9, 2026, 7:59 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $488.55 billion as of October 9, 2026. It is the 27th most valuable company in the world and the 21st biggest in the United States. Its market cap has increased by 19.60% in one year.
Market Cap
488.55B
Enterprise Value
552.87B
1-Year Change
19.60%
Global Rank
Country Rank
#21 United States
Category
ChartMarket Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $488.55B, an increase of 780.44%. That is a compound annual growth rate of 17.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 488.55B | 20.98% |
| Dec 31, 2025 | 403.83B | 28.60% |
| Dec 31, 2024 | 314.02B | 14.77% |
| Dec 29, 2023 | 273.61B | -4.27% |
| Dec 30, 2022 | 285.80B | 19.40% |
| Dec 31, 2021 | 239.37B | 26.54% |
| Dec 31, 2020 | 189.17B | 44.48% |
| Dec 31, 2019 | 130.93B | -5.58% |
| Dec 31, 2018 | 138.67B | -10.18% |
| Dec 29, 2017 | 154.39B | 51.71% |
| Dec 30, 2016 | 101.76B | 5.08% |
| Dec 31, 2015 | 96.84B | -7.12% |
| Dec 31, 2014 | 104.26B | 24.10% |
| Dec 31, 2013 | 84.01B | 51.40% |
| Jan 2, 2013 | 55.49B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.04T |
| Johnson & Johnson | 618.09B |
| Merck & Co. | 351.28B |
| Novartis AG | 268.59B |
| AstraZeneca | 243.74B |
| Amgen | 220.28B |
| Gilead Sciences | 182.40B |
| Novo Nordisk | 165.59B |